跳至主要内容
临床试验/NCT01898234
NCT01898234已完成不适用

Assessment of Subjective and Hemodynamic Tolerance of Different High- and Low-flux Dialysis Membranes in Patients Undergoing Chronic Intermittent Hemodialysis: a Randomized Controlled Trial

Ospedale Regionale di Locarno2 个研究点 分布在 1 个国家目标入组 25 人开始时间: 2012年10月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
25
试验地点
2
主要终点
comparative evaluation of mean hemodynamic parameters (i.e. systolic and diastolic blood pressure, peripheral resistance and cardiac output) during dialysis

研究概览

简要总结

Background:

High- and low-flux dialysis membranes made of different materials may correlate with various hemodynamic tolerance profiles. This study aims to investigate hemodynamic response and incidence of hypotensive episodes by comparing some of the most commonly used high- and low-flux dialyzers.

Methodology:

The study was designed as an open label, randomized, cross-over investigation, including 25 patients undergoing chronic hemodialysis. Four polysulfone dialyzers of 1.8 m2, A (Revaclear, Gambro), B (Helixone high flux, Fresenius), C (Xevonta, BBraun) and D (Helixone low flux, Fresenius), were compared with each other. The hemodynamic profile was assessed with a non-invasive technique and patients were asked to provide tolerance feedback through a questionnaire.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 95 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • age 18 and older
  • ability to understand the information presented and sign the informed consent
  • chronic hemodialysis for at least 8 weeks
  • stable dialysis prescriptions and modality in the 2 weeks prior to protocol implementation

排除标准

  • mental illness;
  • inability to understand the information presented and sign the informed consent;
  • acute disease requiring hospitalization at the time of patient enrolment
  • pregnancy and breast feeding

研究组 & 干预措施

Revaclear

Experimental

干预措施: Revaclear (Device)

Helixone high flux

Experimental

干预措施: Helixone high flux (Device)

Xevonta

Experimental

干预措施: Xevonta (Device)

Helixone low flux

Experimental

干预措施: Helixone low flux (Device)

结局指标

主要结局

comparative evaluation of mean hemodynamic parameters (i.e. systolic and diastolic blood pressure, peripheral resistance and cardiac output) during dialysis

时间窗: 4 weeks

comparative evaluation of subjective tolerance across the various membranes

时间窗: 4 weeks

As to the assessment of subjective tolerance, we decided to administer the questionnaire designed by Cruz et al. \[Cruz DN, Mahnensmith RL, Brickel HM, Perazella MA. Midodrine and cool dialysate are effective therapies for symptomatic intradialytic hypotension. Am. J. Kidney Dis. 1999 Mag;33(5):920-926\] then modified by Teruel et al. \[Teruel JL, Martins J, Merino JL, Fernández Lucas M, Rivera M, Marcén R, et al. Temperature of the dialysis bath and hemodialysis tolerance. Nefrología: PublicaciónOficial De La Sociedad Española Nefrologia. 2006;26(4):461-468\] and to integrate it with a 1 to 10 numerical scale to assess patient well-being

comparative evaluation of Kt/V and of beta-2 microglobulin removal

时间窗: 4 weeks

次要结局

  • comparative analysis of the incidence of symptomatic and non-symptomatic systolic pressure drops (> 20 mmHg)(4 weeks)

研究者

发起方
Ospedale Regionale di Locarno
申办方类型
Other
责任方
Principal Investigator
主要研究者

Luca Gabutti, MD

Prof, Head of Department of Internal Medicine

Ospedale Regionale di Locarno

研究点 (2)

Loading locations...

相似试验